KASABACH MERRITT PHENOMENON

Clinical trials for KASABACH MERRITT PHENOMENON explained in plain language.

Never miss a new study

Get alerted when new KASABACH MERRITT PHENOMENON trials appear

Sign up with your email to follow new studies for KASABACH MERRITT PHENOMENON, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could a lower drug dose be safer and just as effective for kids with rare tumor?

Disease control Recruiting now

This study compares two doses of sirolimus (low vs high) given with prednisolone to children aged 0-18 who have a rare blood vessel tumor called kaposiform hemangioendothelioma with a serious blood clotting problem (Kasabach-Merritt phenomenon). The goal is to see if the lower do…

Matched conditions: KASABACH MERRITT PHENOMENON

Phase: PHASE2, PHASE3 • Sponsor: Yi Ji • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

KASABACH MERRITT PHENOMENON

Get alerted when new KASABACH MERRITT PHENOMENON trials appear

Could a lower drug dose be safer and just as effective for kids with rare tumor?